Dr. Lal PathLabs Limited (LALPATHLAB.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 219.03B |
| Enterprise Value | 218.59B |
| P/E Ratio | 56.66 |
| PEG Ratio | 10.57 |
| Price/Sales Ratio | 10.63 |
| Price/Book Ratio | 12.08 |
| Enterprise/Revenue | 10.63 |
| Enterprise/EBITDA | 33.68 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.19 |
| Operating Margin | 0.23 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.22 |
Income Statement
| Revenue | 27.63B |
| Revenue/Share | 173.11 |
| Gross Profit | 11.61B |
| EBITDA | 8.54B |
| Net Income | 5.05B |
| Diluted EPS | 30.2 |
Balance Sheet
| Total Cash | 13.31B |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 152.18 |
Price History
| 52-Week Change | 19.69 |
| 52-Week High | 2,038.6 |
| 52-Week Low | 1,272.6 |
| Moving Average 50 Days | 1,917.85 |
| Moving Average 200 Days | 1,626.44 |
Statistics
| Average Volume | 353,173 |
| Shares Outstanding | 167.21M |
| % Held by Institutions | 0.08 |
Dividend And Splits
| Trailing Annual Dividend Rate | 16 |
| Trailing Annual Dividend Yield | 0.87 |
| Payout Ratio | 0.19 |
| Last Split Factor | 2:1 |
| Last Split Date | December 19, 2025 |
AD
